In the present study, we report serine and tyrosine phosphorylated ShcA (pSShcA and pYShcA, respectively) by means of a novel two-site chemiluminescence-linked immunoassay (CLISA) in fresh frozen primary tissue samples from 153 selected primary breast cancer patients. Here, SHC1 is linked to breast cancer.